Since 1990, helping busy clinicians master the science and art of caring for people with HIV disease.

The PRN Notebook

07/24/14

HIV and Cure: Another Look at the Reservoir, from Melbourne

07/24/14

Criminalizing Sex Between Men Does Not Stop HIV Spread - Human Rights and Public Health Converge

07/23/14

More from Melbourne: “Intermittent” PrEP

07/23/14

Report from Melbourne: The role of adherence in PrEP

07/22/14

HIV/HCV Coinfection Highlights at the 20th Internaltional Conference on AIDS

08/20/14

IAS 2014: Ending AIDS by 2030—Finishing the Job

03/06/2104

CROI 2014: Chronic Inflammation - Can Anything Be Done?

03/06/2104

Can the CD4/CD8 Ratio Predict Risk of Co-Morbidities in HIV?

03/06/2014

Inflammation and Comorbidities of HIV: CROI 2014

03/06/2014

Antiretrovirals in the Pipeline: CROI 2014

03/05/2014

HIV-infected Persons Have Higher Rates of Cancer-Specific Mortality

03/06/2014

No HIV Transmission with Condomless Sex when HIV+ Partners are Virologically Suppressed: CROI 2014

03/06/2104

Vitamin D and Calcium Attenuates Bone Loss While on ART: CROI 2014

03/05/2104

CROI 2014: Are Any Guidelines-preferred ART Regimens “More Preferred”?

03/05/2014

Nucleoside-sparing vs. Standard Nucleoside-containing Initial ART Compared: CROI 2014

03/05/2014

Transmitted Drug Resistance Rates Higher with More Sensitive Genotypic Screening: CROI 2014

03/03/2014

HCV Treatment without Interferon, Gets Shorter and Better: CROI 2014

03/03/2014

2nd Gen HCV Protease Inhibitors Improve Tolerability & HCV Outcomes in HIV Coinfection: CROI 2014

10/11/2013

New Treatments for HIV/Hepatitis C Co-infection Presented at ID Week 2103.

10/11/2013

Premature Mortality in HCV-infected Individuals Reported at ID Week 2013

10/11/2013

New Studies of Interferon and Ribavirin-free Treatment of Hepatitis C at ID week 2013

10/11/2013

New Regimens for Non-genotype 1 HCV Mono-infection Reported at ID Week 2013

10/09/2013

Osteoporosis and Inflammation Linked at ID Week 2013

10/09/2013

Is Etravirine an Acceptable Alternative to Efavirenz in the Treatment-naive?

10/07/2013

Polypharmacy and Adherence: ID Week 2103

10/07/2013

Polypharmacy and Comorbidities in HIV: Associations with Mortality Discussed at ID Week 2013

10/07/2013

Efavirenz Linked to Suicide Risk at ID Week 2013

10/07/2013

Can Switching Antiretroviral Agents Reduce Hyperlipidemia in HIV? A Report from ID Week 2013

10/07/2013

Worse Prognosis for HIV in Acute Coronary Syndrome: ID Week 2013

09/19/2013

New Study of Raltegravir in Pregnancy at ICAAC 2013

09/18/2013

The Search for the Cure— A New Study at ICAAC 2103

09/18/2013

Support for Treatment of HCV in Co-infected Patients with Moderate Fibrosis Reported at ICAAC 2013

09/17/2013

Investigational Antiretrovirals at ICAAC 2013: Tenofovir Alafenamide

09/17/2013

Early Findings on PrEP Utilization and a Promising New PrEP Strategy presented at ICAAC 2013

09/16/2013

More on Dolutegravir at ICAAC 2013: Pharmacokinetics

09/16/2013

Is Raltegravir Best for HIV-Infected Individuals Treated for Cancer? News from ICAAC 2013

09/16/2013

New Studies of Dolutegravir at ICAAC 2013.

09/16/2013

Managing Cardiovascular Disease in HIV-Infection: News from ICAAC 2013

09/16/2013

Osteoporosis in HIV: The Effects of Antiretroviral Agents are Further Defined at ICAAC 2013

07/03/2013

IAS 2013: PrEP in Women Trying to Conceive—Infected Male Partner Needs to be on ART

07/03/2013

IAS 2013: Earlier Treatment Reduces HIV Reservoir

07/01/2013

IAS 2013: Linkage to Care Following Home-based HIV Testing

07/01/2013

IAS 2013: A Global HIV Perspective, Spotlight on Cambodia

06/30/2013

IAS 2013: World Health Organization Guidelines for Earlier HIV Treatment

03/06/2013

CROI 2013: Promising interferon-free regimens in HCV mono-infection

03/06/2013

CROI 2013: Inflammation & coronary heart disease are more aggressive in HIV

03/06/2013

CROI 2013: Random anal biopsies improve detection of high-grade precancerous lesions

03/06/2013

CROI 2013: Adding telaprevir improves response & shortens treatment of acute HCV in HIV-positive MSM

03/06/2013

CROI 2013: Triple therapy for HCV-HIV coinfection with 2nd generation HCV protease inhibitors

03/06/2013

CROI 2013: Must NRTIs be included in new regimen after failing a PI-containing regimen?

03/05/2013

CROI 2013: Is heart failure a looming problem in HIV?

03/05/2013

CROI 2013: Obesity in HIV

03/05/2013

CROI 2013: A closer look at HIV-positives lost to follow-up

03/05/2013

CROI 2013: Drug-resistant HIV transmission is increasing in NYC immigrant populations

03/05/2013

CROI 2013: Major HIV drug resistance mutations in ARV-naïve adolescents and young adults

03/04/2013

CROI 2013: More evidence for higher risk of cardiovascular disease among HIV-positives

03/04/2013

CROI 2013: Triple therapy for HCV co-infected patients who failed dual therapy

03/04/2013

CROI 2013: Long-acting integrase inhibitor prevents rectal transmission of SHIV in macaques

03/04/2013

CROI 2013: Monthly tenofovir intravaginal ring prevents SHIV infection in female macaques

03/04/2013

CROI 2013: Pre-exposure prophylaxis fails to protect women from HIV in African study

Friday, July 27, 2012

Ongoing research on licensed ARVs presented at AIDS 2012

Thursday, July 26, 2012

More starting treatment, with more options for ART in the pipeline

Thursday, July 26, 2012

Expanding HIV testing and treatment globally

Wednesday, July 25, 2012

HIV vaccine update AIDS 2012 in Washington DC

Tuesday, July 24, 2012

US trade policies impact global drug pricing

Monday, July 23, 2012

More about: Towards an HIV cure

Saturday, July 21, 2012

Towards an HIV Cure: Workshop Summary

Saturday, July 21, 2012

Pre-IAS meeting spotlights MSM and transgender health issues

Tuesday, March 6, 2012

Long-acting, intramuscular formulation of ripilvirine for PrEP

Tuesday, March 6, 2012

Improved rectal microbicide for PrEP is safe and well-tolerated

Tuesday, March 6, 2012

No sign of tenofovir-induced resistance when PrEP with vaginal gel fails

Tuesday, March 6, 2012

Intracellular drug levels and PrEP dosing strategies

Tuesday, March 6, 2012

Plasma drug levels as markers of adherence in PrEP

July 20, 2011

Short course antiretroviral therapy in primary HIV infection: the SPARTAC results

July 20, 2011

Elvitegravir Noninferior to Raltegravir

July 20, 2011

New point-of-care test for cryptococcal antigen may save thousands of lives.

July 20, 2011

PrEP: Adherence Matters

July 18, 2011

More studies show success of pre-exposure prophylaxis in preventing HIV transmission

July 19, 2011

Session dedicated to adolescent health at IAS Conference, Rome

July 20, 2011

The IAS calls for therapeutic and treatment strategies to cure HIV/AIDS

July 19, 2011

27% reduction in HIV disease progression among HSV-2 coinfected subjects treated with acyclovir

July 18, 2011

Treatment as Prevention: 96% reduction in HIV transmission among HIV-serodiscordant partnerships

July 18, 2011

IAS 2011: Disappointing results from Raltegravir intensification study for immune failure.

July 19, 2011

IAS 2011: Comorbidities and non-AIDS events

July 19, 2011

IAS 2011: Antiretroviral drugs and risk of cardiovascular disease

July 19, 2011

IAS 2011: Interpreting the Data: Selection Bias?

July 19, 2011

IAS 2011: Cardiovascular Risk Management: A Multidisciplinary Effort

July 18, 2011

IAS 2011: Final Data on ARIES Study Released

July 18, 2011

IAS 2011: Initial Results Released on Simplified NRTI-Sparing Strategy: RAL + DRV/r

July 18, 2011

IAS 2011: Treatment = Prevention

March 1, 2011

NanoART for Improved Drug Delivery

March 1, 2011

Low-Dose Ritonavir Does Not Affect PK of Investigational HCV Protease Inhibitor

February 28, 2011

Study Shows Rectal-Specific Formulation of Tenofovir Gel is Needed

February 28, 2011

Infusion of Genetically-Modified HIV-Resistant CD4 Cells Show Potential Benefit

February 28, 2011

Post-Exposure Topical Vaginal Gel Containing Raltegravir Protects Macaques from SHIV Infection

February 28, 2011

Intermittent Truvada Protects Against Rectal Transmission of Emtricitabine-Resistant SHIV

12/02/10

UNITED KINGDOM:  AIDS ‘Fatigue’ May Cause Lack of Funds, Former UNAIDS Head Says

12/01/10

UNITED STATES:  More, but Not Enough, Americans Get AIDS Tests

12/01/10

GLOBAL:  Complacency Fuels New AIDS Surge in West: UN

12/01/10

GLOBAL:  UNICEF Says HIV-Free Generation Is Achievable

image

TRANSMISSION

Transmission, Diagnosis and the HIV Epidemic

View Article List

image

PROGRESSION

Pathogenesis and Progression of HIV Disease.

View Article List

image

MANAGEMENT

Treatment, Resistance and Management of HIV/AIDS

View Article List

image

COMPLICATIONS

Complications and Comorbidities

View Article List

image

COINFECTIONS

Coinfections and Opportunistic Infections

View Article List

Visit The PRN Notebook